Life Saving Drugs Program – Pompe disease – Review summary and expert panel recommendations

This Pompe disease review considered alglucosidase alfa. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations.

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.